Surgery Partners Prices $425 Million Senior Unsecured Notes Offering
Written by Emily J. Thompson, Senior Investment Analyst
Source: Globenewswire
Updated: 18 minutes ago0mins
- Bond Offering Size: Surgery Partners' wholly-owned subsidiary, Surgery Center Holdings, Inc., has successfully priced $425 million of 7.250% senior unsecured notes, expected to close on December 16, 2025, enhancing the company's financing flexibility.
- Clear Use of Proceeds: The net proceeds from this bond offering will be utilized for general corporate purposes, including repaying outstanding borrowings under its revolving credit facility, thereby optimizing the company's capital structure and reducing financial costs.
- Market Positioning: As a leading healthcare services company in the U.S., Surgery Partners operates over 200 locations across 30 states, continuously expanding its surgical services business to provide high-quality, cost-effective solutions for patients and physicians.
- Compliance and Risk Advisory: This bond offering complies with Rule 144A of the Securities Act, targeting only qualified institutional buyers, and the unregistered securities may face liquidity risks, necessitating attention to market changes that could impact the company's finances.
SGRY.O
$0.0000%Past 6 months
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
No Data
Powered By
Intellectia
Analyst Views on SGRY
Wall Street analysts forecast SGRY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SGRY is 26.60 USD with a low forecast of 18.00 USD and a high forecast of 36.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Analyst Rating
8 Buy
3 Hold
0 Sell
Moderate Buy
Current: 16.530
Low
18.00
Averages
26.60
High
36.00
Current: 16.530
Low
18.00
Averages
26.60
High
36.00
JPMorgan
Neutral
downgrade
$27 -> $20
2025-11-24
Reason
JPMorgan
Price Target
$27 -> $20
2025-11-24
downgrade
Neutral
Reason
JPMorgan lowered the firm's price target on Surgery Partners to $20 from $27 and keeps a Neutral rating on the shares. The firm updated the company's model post the Q3 report.
Barclays
Equal Weight
downgrade
$24 -> $18
2025-11-21
Reason
Barclays
Price Target
$24 -> $18
2025-11-21
downgrade
Equal Weight
Reason
Barclays lowered the firm's price target on Surgery Partners to $18 from $24 and keeps an Equal Weight rating on the shares. The firm says employer-sponsored insurance coverage looks under pressure but will be "potentially masked" by positive Affordable Care Act trends benefiting hospitals.
Mizuho
Outperform
to
NULL
downgrade
$28 -> $22
2025-11-17
Reason
Mizuho
Price Target
$28 -> $22
2025-11-17
downgrade
Outperform
to
NULL
Reason
Mizuho lowered the firm's price target on Surgery Partners to $22 from $28 and keeps an Outperform rating on the shares. The firm reduced its estimates for Surgery Partners to account for the lower-than-expected performance, lower earnings visibility due to payer mix pressure, and to remove M&A from its forecasts. Though the payer mix volume pressures reduce earnings visibility, the firm believes its estimates reflect that risk.
UBS
Buy
downgrade
$34 -> $29
2025-11-13
Reason
UBS
Price Target
$34 -> $29
2025-11-13
downgrade
Buy
Reason
UBS lowered the firm's price target on Surgery Partners to $29 from $34 and keeps a Buy rating on the shares.
See All Ratings
About SGRY
Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility Services segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of 162 surgical facilities comprised of 143 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 250 locations in 30 states, including short-stay surgical hospitals.
About the author
Preview
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sigh Up to Get Intellectia Insights
What is the primary goal of the Surgery Partners-Baylor Scott & White joint venture?
How does the partnership aim to enhance local patient care quality?
How might this joint venture impact Surgery Partners' market growth in Texas?
What future opportunities could arise from attracting new physician partners?